Initially, the patient with stemness gene amplifications had a high concentration of EpCam+CD44+CD24– tumor stem cells – more than 50%, while patient Ti41749/17 had a level slightly above 30% and a two-fold higher concentration of EpCam+CD44hiCD24– cells (37% compared with 18%). This evidence concerns the gene CD24 and neoplasm.